|
|||||
|
|
Refractory myasthenia gravis exacerbation triggered By pembrolizumab |
|
| Authors: | Damien E. Earl MD PhD Aaron I. Loochtan DO Richard S. Bedlack MD PhD |
| Affiliation: | 1. Department of Neurology, Duke University Hospital, Durham, North Carolina, USA;2. Department of Neurology, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA |
| Abstract: | |
| Keywords: | exacerbation immune checkpoint inhibitor immune‐related adverse event melanoma myasthenia gravis pembrolizumab |